POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin disorders) is a rare multisystemic disease associated with plasma cell dyscrasia. A 68-year-old woman with chronic renal insufficiency and arterial hypertension included in her medical history was admitted to the hospital with confusion, somnolence and asthenia. She presented ascites, hepatosplenomegaly, leg oedema, distal dysesthesias, leuconychia and multiple nodular purple red angiomas on the trunk, upper limbs and fingers. Hypothyroidism was revealed in the laboratory investigations and monoclonal IgG peak in immunoelectrophoresis. Electromyography showed both demyelinisating and axonal degenerative neuropathy. The diagnosis of POEMS syndrome was based on the dermatopathological examination of a cutaneous angioma; histology revealed features of glomeruloid angioma, a specific marker of this syndrome.

Keywords:
POEMS syndrome, Glomeruloid angioma
1.
Rose C, Mahieu M, Hachulla E, Facon T, Hatron PY, Bauters F, Devulder B: Le POEMS syndrome. Rev Méd Interne 1997;18:553–562.
2.
Rongioletti F, Gambini C, Lerza R: Glomeruloid hemangioma: A cutaneous marker of POEMS syndrome. Am J Dermatopathol 1994;16:175–178.
3.
Crow RS: Peripheral neuritis in myelomatosis. Br Med J 1956;ii:802–804.
4.
Soubrier M, Dubost JJ, Sauvezie B: POEMS syndrome, a study of 25 cases and a review of the literature. Am J Med 1994;97:543–553.
5.
Scheys S: Osteosclerotic myeloma and POEMS syndrome. Blood Rev 1996;10:75–80.
6.
Masson C, Krepsi Y: POEMS syndrome. Presse Méd 1994;23:646–648.
7.
Berson A, Fabre M, Buffet C, Rougier P, Guillaume JC, Venencie PY, Schaison G, Pateron D, Charpentier P, Etienne JP: Une cause rare d’ascite: le syndrome POEMS. Gastroentérol Clin Biol 1990;14:675–679.
8.
Rey JP, Modesto A, Orfila C, Cozette P, Donnadieu P, Lauze I, Heran B, Bertand JL, Camo J, Negre C: Renal involvement in POEMS syndrome. Néphrologie 1994;15:391–394.
9.
Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB: A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999;14:2370–2378.
10.
Fukatsu A, Tamai H, Nishikawa K, Matsukawa W, Yoshida F, Matsuo S, Takeda A, Kodera K, Morozumi K, Ito Y, Miyakawa K, Toriyama T, Kawahara H, Shigematsu H: The kidney disease of Crow-Fukase (POEMS) syndrome: A clinico-pathological study of four cases. Clin Nephrol 1991;36:76–82.
11.
Dereure O, Guillot B, Dandurand M, Bataille R, Chertok P, Donadio D, Blotman F, Barneon G, Guilhou JJ: Les signes cutanés du syndrome POEMS. Ann Dermatol Vénéréol 1990;117:283–290.
12.
Zea-Mendoza AC, Alonso-Ruiz A, Garcia-Vadillo A, Moreno-Caparros A, Beltran-Gutierrez J: POEMS syndrome with neuroarthropathy and nodular regenerative hyperplasia of the liver. Arthritis Rheum 1984;27:1053–1057.
13.
Kanitakis J, Roger H, Soubrier H, Dubost JJ, Chouvet B, Souteyrand P: Cutaneous angioma in POEMS syndrome. Arch Dermatol 1988;124:695–698.
14.
Chan JKC, Fletcher CDM, Hicklin GA, Rosai I: Glomeruloid hemangioma: A distinctive cutaneous lesion of multicentric disease associated with POEMS syndrome. Am J Surg Pathol 1990;14:1036–1046.
15.
Gherardi R, Belec L, Soubrier M, Malapert D, Zuber M, Viard JP, Intrator L, Degos JD, Authier FJ: Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996;87:1458–1465.
16.
Andres E, Courouau F, Kaltenbach G, Maloisel, Imler M: Syndrome POEMS: rôles et intérêts de l’interleukine 6. Rev Méd Interne 1996;17:145–149.
17.
Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M: Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998;21:1390–1397.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.